EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Predictors of low and very low bone mineral density in long‐term childhood acute lymphoblastic leukemia survivors: Toward personalized risk prediction

Geneviève Nadeau iD, Mariia Samoilenko, Melissa Fiscaletti, Louis-Nicolas Veilleux iD, Daniel Curnier iD, Caroline Laverdière, Daniel Sinnett, Maja Krajinovic, Geneviève Lefebvre, Nathalie Alos

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Geneviève Nadeau und 9 weiteren Autor:innen. Beteiligte Einrichtung: CHU Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Bone Density, Cancer Survivors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Garron Family Cancer Centre, Cancer Research Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cohorts of childhood acute lymphoblastic leukemia (cALL) survivors reaching adulthood are increasing. Approximately 30% of survivors meet criteria for low bone mineral density (BMD) 10 years after diagnosis. We investigated risk factors for low BMD in long‐term cALL survivors.

Methods

We recruited 245 cALL survivors from the PETALE (Prévenir les effets tardifs des traitements de la leucémie aiguë lymphoblastique chez l'enfant) cohort, who were treated with the Dana Farber Cancer Institute protocols, did not experience disease relapse or hematopoietic stem cell transplants, and presented with more than 5 years of event‐free survival. Median time since diagnosis was 15.1 years.

Results

Prevalence of low DXA‐derived BMD ( Z ‐score ≤−1) ranged between 21.9% and 25.3%, depending on site (lumbar spine (LS‐BMD), femoral neck (FN‐BMD), and total body (TB‐BMD), and between 3.7% and 5.8% for very low BMD ( Z ‐score ≤−2). Males had a higher prevalence of low BMD than females for all three outcomes (26%–32% vs. 18%–21%), and male sex acted as a significant risk factor for low BMD in all models. Treatment‐related factors such as cumulative glucocorticoid (GC) doses and cranial radiation therapy (CRT) were associated with lower BMDs in the full cohort and in females at the FN‐BMD site.

Conclusion

Low and very low BMD is more prevalent in male cALL survivors. Male sex, high cumulative GC doses, CRT, risk group, and low body mass index (BMI) were identified as risk factors for low BMD. A longer follow‐up of BMD through time in these survivors is needed to establish if low BMD will translate into a higher risk for fragility fractures through adulthood.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaBone DensityCancer SurvivorsHumansMaleFemaleChildAdolescentRisk FactorsAdultChild, PreschoolFollow-Up StudiesYoung AdultPrognosisInfant

Stichwörter der Autor:innen

bone health in childrenbone mineral densitycancer treatment toxicitychildhood acute lymphoblastic leukemiachildhood cancer survivorlate cancer effects

Autor:innen und Institutionen

  • CHU Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada.
  • Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Division of Endocrinology, Sainte-Justine University Hospital Centre, Montreal, Quebec, Canada.
  • Montreal Shriners Hospital for Children, Montreal, Quebec, Canada.
  • School of Kinesiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Division of Hemato-Oncology, Sainte-Justine University Hospital Centre, Montreal, Quebec, Canada.

ORCID-Profile: Geneviève Nadeau, Louis-Nicolas Veilleux, Daniel Curnier

Förderung

  • CIHR
  • Garron Family Cancer Centre
  • Cancer Research Society
  • CHU Sainte-Justine Foundation
  • C17 Children's Cancer and Blood Disorders
  • Canadian Cancer Society Research Institute
  • Pediatric Oncology Group of Ontario
  • Fonds de Recherche du Québec-Santé

Zitieren

APA

Nadeau, G., Samoilenko, M., Fiscaletti, M., Veilleux, L. N., Curnier, D., Laverdière, C., Sinnett, D., Krajinovic, M., Lefebvre, G., & Alos, N. (2024). Predictors of low and very low bone mineral density in long‐term childhood acute lymphoblastic leukemia survivors: Toward personalized risk prediction. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31047

Vancouver

Nadeau G, Samoilenko M, Fiscaletti M, Veilleux LN, Curnier D, Laverdière C, et al. Predictors of low and very low bone mineral density in long‐term childhood acute lymphoblastic leukemia survivors: Toward personalized risk prediction. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31047

BibTeX
@article{Nadeau2024,
  author = {Nadeau, Geneviève and Samoilenko, Mariia and Fiscaletti, Melissa and Veilleux, Louis-Nicolas and Curnier, Daniel and Laverdière, Caroline and Sinnett, Daniel and Krajinovic, Maja and Lefebvre, Geneviève and Alos, Nathalie},
  title = {Predictors of low and very low bone mineral density in long‐term childhood acute lymphoblastic leukemia survivors: Toward personalized risk prediction},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31047}
}
Kostenlos starten →